Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mariana Perepitchka"'
Autor:
Yekaterina Galat, Yuchen Du, Mariana Perepitchka, Xiao-Nan Li, Irina V Balyasnikova, William T Tse, Svetlana Dambaeva, Sylvia Schneiderman, Philip M Iannaccone, Oren Becher, Douglas K Graham, Vasiliy Galat
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTBackground Immunotherapeutic innovation is crucial for limited operability tumors. CAR T-cell therapy displayed reduced efficiency against glioblastoma (GBM), likely due to mutations underlying disease progression. Natural Killer cells (NKs)
Externí odkaz:
https://doaj.org/article/f5129c7ae29c4141b8f9be0db6d6b0b2
Autor:
Philip M. Iannaccone, Joon Won Yoon, Xenia A. Glukhova, Xiao-Nan Li, Robert L. Taylor, Yekaterina Galat, Mariana Perepitchka, Igor P. Beletsky, Vasiliy Galat, David O. Walterhouse, Haigang Gu
Publikováno v:
Stem Cells (Dayton, Ohio)
GLI1 is one of three GLI family transcription factors that mediate Sonic Hedgehog signaling, which plays a role in development and cell differentiation. GLI1 forms a positive feedback loop with GLI2 and likely with itself. To determine the impact of
Publikováno v:
Oncotarget
Trisomy 21 (T21), known as Down syndrome (DS), is a widely studied chromosomal abnormality. Previous studies have shown that DS individuals have a unique cancer profile. While exhibiting low solid tumor prevalence, DS patients are at risk for hematol
Autor:
Irina Elcheva, Mariana Perepitchka, Vasiliy Galat, Stephen Iannaccone, Philip M. Iannaccone, Yekaterina Galat
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Scientific Reports
Scientific Reports
Down syndrome (DS) is a congenital disorder caused by trisomy 21 (T21). It is associated with cognitive impairment, muscle hypotonia, heart defects, and other clinical anomalies. At the same time, individuals with Down syndrome have lower prevalence
Autor:
Philip M. Iannaccone, Mariana Perepitchka, Vasiliy Galat, Mary J.C. Hendrix, Lawrence J. Jennings, Yekaterina Galat
Publikováno v:
Stem Cells and Development
Induced pluripotent stem cells (iPSCs) have enormous potential in regenerative medicine and disease modeling. It is now felt that clinical trials should be performed with iPSCs derived with nonintegrative constructs. Numerous studies, however, includ